Related Experiment Video
Updated: Mar 25, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
8.2K
[Delirium Prevention]
Diana Restrepo Bernal1, Jorge Andrés Niño García2, Daniel Eduardo Ortiz Estévez3
1Universidad CES, Colombia.
Revista Colombiana De Psiquiatria
|February 21, 2016
Summary
Preventing hospital delirium is crucial. Non-pharmacological strategies are effective and cost-efficient for high-risk patients, though more research is needed for non-surgical populations.
Area of Science:
- Geriatric Medicine
- Neuroscience
- Critical Care Medicine
Background:
- Delirium is a common neuropsychiatric syndrome in hospitalized patients, indicating a poor prognosis.
- Prevention of delirium is a key strategy to reduce its incidence and associated complications.
- Understanding delirium's risk factors and pathophysiology informs prevention strategies.
Purpose of the Study:
- To review recent findings and strategies for preventing delirium.
- To synthesize current evidence on delirium prevention interventions.
Main Methods:
- A non-systematic review of scientific articles published in the last decade.
- Searches conducted in major databases (MEDLINE, Cochrane, EMBASE, Ovid, ScienceDirect) using terms 'delirium' and 'prevention'.
Main Results:
- Non-pharmacological interventions are supported by current evidence for daily implementation in high-risk patients due to ease of use and cost-effectiveness.
- Pharmacological strategies for delirium prophylaxis have limited evidence for routine use.
- Consensus exists against routine use of antipsychotics in surgical patients and dexmedetomidine in ICU patients for delirium prevention.
Conclusions:
- Further high-quality clinical trials are necessary, particularly focusing on non-surgical patient populations.
- Continued research is needed to expand evidence-based delirium prevention strategies.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:30Dementia
676
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
676
01:26Psychosis: Goals of Pharmacotherapy
662
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
662
01:28Drug Therapy
392
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
392
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
524
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
524